LATEST ARTICLES

Changing The Narrative: 10 Recommendations for Caring for Young Adults With Lung Cancer

By Narjust Florez, MD, Fatima Wilder, MD, MSc, Lauren Kiel, BS, and Rebekah Kaufman, MSIt is about time that we change the narrative of lung cancer being a disease that impacts elderly men with a smoking history into one that encompasses our modern reality of an inclusive patient population, including women and especially including...

Erin Parry, MD, PhD

Researcher Spotlight Home » Erin Parry, MD, PhD Researcher Spotlight: Erin Parry, MD, PhD DANA-FARBER CANCER INSTITUTE Dr. Parry’s research is centered at the intersection of genomics and cancer immunotherapy, with a focus on B cell lymphomas. Her LRF research project is aimed at understanding...

Wen-Hsuan Wendy Lin, MD, PhD

Researcher Spotlight Home » Wen-Hsuan Wendy Lin, MD, PhD Researcher Spotlight: Wen-Hsuan Wendy Lin, MD, PhD COLUMBIA UNIVERSITY Peripheral T-cell lymphomas (PTCL) represent a group of aggressive blood cancers with poor outcomes. A common phenomenon in PTCL is the development of a proinflammatory microenvironment, in...

Andrew Jallouk, MD, PhD

Researcher Spotlight Home » Andrew Jallouk, MD, PhD Researcher Spotlight: Andrew Jallouk, MD, PhD VANDERBILT UNIVERSITY MEDICAL CENTER Errol M. Cook Memorial Scholar Chimeric antigen receptor (CAR) T-cell therapy represents a highly effective treatment option for many types of lymphoma. Currently available CAR T-cell therapies are...

Alexander Boardman, MD

Researcher Spotlight Home » Alexander Boardman, MD Researcher Spotlight: Alexander Boardman, MD MEMORIAL SLOAN KETTERING Dobosh Family Scholar Treatment of lymphoma has been revolutionized by the emergence of CD19-directed chimeric antigen receptor (CAR) T-cell therapies, but many patients still relapse after treatment. Dr. Boardman’s LRF research...